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Fipronil  is  a phenylpyrazole  class  insecticide.  It is  widely  used  as  an  insecticide  in  agriculture  and  in the
control  of ectoparasites  in veterinary  medicine.  The  application  of  ﬁpronil  in  an  injectable  form  (sub-
cutaneously)  becomes  an  innovation,  since  there  is  no commercially  available  preparation  containing
ﬁpronil  herein.  The  present  study aimed  at ﬁpronil  usage,  applied  subcutaneously  in cattle,  to  con-
trol  Rhipicephalus  microplus.  The  assessing  criteria  used  in the  research  have  been  the  construction  of
the  plasma  concentration  curve  and  efﬁcacy  studies.  A  method  using  High  Performance  Liquid  Chro-
matograph  with  ultraviolet  detection  was  developed  for determination  of  ﬁpronil  in  bovine plasma
samples,  providing  a fast and simple  process  with  good  reproducibility  and  low  limit  of quantiﬁca-
tion.  The  validation  of the analytical  method  showed  linearity,  selectivity,  precision,  accuracy,  sensitivity
and  stability,  thus  proving  it as suitable  for routine  analysis.  This method  showed  to be an important
investigative  tool  in the  analysis  of ﬁpronil  plasma  concentration  in  cattle.  Fipronil  administered  via
subcutaneous  in bovine  reached  the systemic  circulation  (Cmax = 378.06  ±  137.44  ng/mL),  was  quickly
absorbed  (tmax = 10 ± 0.87  h),  and  its  elimination  occurred  slowly  (t1/2 =  12  days),  while  maintaining  quan-
tiﬁable  blood  plasma  levels  (23.79  ± 12.16  ng/mL)  for up to 21  days  after  the  treatment  with  a  1 mg/kg
dosage.  The  in vivo  efﬁcacy  tests  proved  that  ﬁpronil  applied  subcutaneously  in a single  dose  of  1 mg/kg
in  cattle  exhibited  a mean  efﬁcacy  of  82.41%  against  R. microplus.  The  potential  of  subcutaneous  injection
as  an  alternative  treatment  route  in  cattle  encourage  the  development  of an injectable  formulation  of
ﬁpronil.
© 2016  Elsevier  B.V.  All  rights  reserved.. Introduction
Fipronil (FIP) is a broad-spectrum phenylpyrazole recom-
ended for agricultural, phytosanitary and veterinary uses (Tingle
t al., 2003). Is very effective against grasshoppers, mosquitoes,
eas and ticks both larval and adult stages (Chanton et al., 2001;
ajoud et al., 2003). Its mechanism of action involves neurotrans-
itter aminobutyric acid (GABA) block (Raugh et al., 1990) via
hloride channels resulting in insect death (Postal et al., 1995).
ABA plays an important role in neural transmission of both ver-
ebrates and invertebrates, however FIP presents some selectivity
ince it’s binding with GABA receptor is weaker in vertebrates,
eing much more toxic to these parasites than for mammals (Hainzl
nd Casida, 1996; Matsuda et al., 2001; Payne et al., 2001; Hovda
nd Hoser, 2002).
∗ Corresponding author.
E-mail address: yaracid@yahoo.com.br (Y.P. Cid).
ttp://dx.doi.org/10.1016/j.vetpar.2016.02.008
304-4017/© 2016 Elsevier B.V. All rights reserved.Since the main tick species, that compromises the health and
productivity of cattle in Brazil is the Rhipicephalus microplus, its
control has become a focus of attention of the veterinary pharma-
ceutical industry as well as government agencies, and educational
and research institutions. Possible innovations include the devel-
opment of new pharmaceutical forms that promote a broader
spectrum of action, ease of use, and safety for the environment and
the applicator (Taylor, 2001).
Currently, FIP is commercially available only in topical forms
(pour-on) for tick control in cattle. Efﬁcacies against R. microplus
after single treatment of topical formulation in cattle have been
demonstrated (Davey et al., 1998). The injectable route has some
advantages over topically, as the preference of the owner and/or
veterinarian by injection application method and the issue of envi-
ronmental impact. Furthermore, topical products would be more
exposed to environmental degradation, like mechanical removal
by action of rain or degradation of photosensitive drugs by action
of sunlight. In the speciﬁc case of FIP, Davey et al. (1999) demon-
strated that the persistence time against reinfection after a single
Y.P. Cid et al. / Veterinary Para
Fig. 1. Mean ± SE concentration of ﬁpronil in plasma of cattle treated with a single
subcutaneous injection of ﬁpronil solution at dose of 1 mg/kg body weight.
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and −1); D = mean ticks of treated group on the day of treatment
(day 0), B = mean ticks of untreated group on the day of treatmentpplication of FIP “pour-on” reduced signiﬁcantly after exposure to
unlight.
The therapeutic action of drugs is dependent on their effec-
ive concentration at the site of action for a given period of time.
nce a drug concentration at the site of action is in equilibrium
ith the same concentration in the bloodstream, for most drugs,
he measurement of drug concentration in plasma becomes its
easurement at its site of action (Shargel et al., 2004). The drug
vailability from the dosage form plays a critical role in a drug’s
linical efﬁcacy (Shargel et al., 2004). Therefore, the drug’s plasma
roﬁle from dosage form studies is crucial in assessing the perfor-
ance of new formulations.
Thus, this study was designed to determine the potential of
ubcutaneous injection of FIP as an alternative treatment route in
attle. The aim of the study was to investigate the plasma disposi-
ion and efﬁcacy of FIP in cattle after subcutaneous administration.
. Material and methods
.1. Pharmacokinetics analysis
A dose of 1 mg/kg b.w. of FIP solution in glycerol for-
al/propylene glycol was administrated by single sub-cutaneous
njection to 12 male zebu calves, which have been fed with hay
ree of larvae tick and kept individually in stalls for 30 days before
reatment. As a result, these animals remained free of ticks through-
ut the experimental period. Blood was collected in heparin tubes
y jugular venipuncture of cattle before and at 1, 2, 4, 8, 10, 12,
4, 36 and 48 h and 3, 7, 14, 21 and 28 days after administration.
lasma was obtained by centrifugation at 756g for 10 min  at 4 ◦C
nd stored at −20 ◦C until analysis. Animal procedures were con-
ucted in accordance with accepted standards for good clinical
ractice from The European Agency for the Evaluation of Medicinal
roducts (VICH, 2000).
The plasma concentration vs. time curves obtained after each
reatment in individual animals was ﬁtted with the PK Functions
or Microsoft Excel program (Allergan, Irvine, CA 92606, USA).
harmacokinetic parameters for each animal were analyzed using
ompartmental model analysis. The maximum plasma concentra-
ion (Cmax) and time to reach maximum concentration (tmax) were
btained from the plotted concentration time curve of each drug
n each animal. The trapezoidal rule was used to calculate the area
nder the plasma concentration time curve (AUC).sitology 220 (2016) 4–8 5
2.2. Analytical procedure
The plasma concentrations of FIP were analyzed by high per-
formance liquid chromatography (HPLC) with ultraviolet (UV)
detection following solid phase extraction (SPE) procedure accord-
ing to a previously described method (Cid et al., 2012a).
Brieﬂy, plasma samples were subjected to the SPE clean-up
using Oasis® HLB cartridges (Waters, Massachusetts, USA) using
methanol as eluent solvent. The chromatographic separation was
performed using a Symmetry C18 column (5 m,  4.6 × 250 mm)
(Waters, Massachusetts, USA) maintained at 25 ◦C. The mobile
phase consisted of acetonitrile: water (60:40, v/v) with a ﬂow rate of
1.0 mL/min. The UV wavelength was  set at 210 nm and the injection
volume was  10 L.
2.3. Efﬁcacy studies
To evaluate the in vivo efﬁcacy of the FIP applied subcutaneously
was used the methodology developed by Holdsworth et al. (2006)
and recommended by WAAVP – World Association for advance-
ment of Veterinary Parasitology (2006) – for testing acaricide in
ruminants.
Twelve zebu calves, each weighing 250 ± 5 kg, were randomly
divided into two  groups of six animals per group. One group of
six calves designated as an untreated group served as a nega-
tive control group to which the treated group was compared. The
second group of calves was  treated with FIP solution in glycerol
formal/propylene glycol at dose of 1 mg/kg b.w. by single subcu-
taneous injection. All calves were weighed on certiﬁed scales one
day before application of the test material to ensure proper dosing.
Throughout the study all animals were held in an open-sided barn
under ambient conditions, except that a roof prevented direct sun-
light or rainfall from reaching the animals. During the study each
animal was held in an individual stanchion on wooden pallets so
that ticks could be collected every 24 h.
The RS strain of R. microplus,  courtesy of Veterinary Research
Institute Desiderius Finamor (Rio Grande do Sul) was used for arti-
ﬁcial infestation of animals. This was chosen to carry out the clinical
efﬁcacy trial because it showed greater susceptibility to FIP in an
in vitro assay (Drummond et al., 1973) comparing three distinct
populations (Cid et al., 2012b).
All calves (both groups) were artiﬁcially infested with approx-
imately 2500 larval R. microplus ticks that were 2–4 weeks old
on days −23, −21, −19, −17, −15, −13, −11, −9, −7, −5, −3 and
−1 before FIP treatment. This procedure and interval ensures an
infestation with all stages of the tick (larva, nymph and adult) dur-
ing treatment. Throughout the whole experiment, animals were
kept individually in stalls with pallets so that ticks could be col-
lected daily. The collection of naturally detached engorged females
was performed by manual recovery from the waste produced after
washing the stalls.
On days −3, −2 and −1, engorged females recovered from each
animal were quantiﬁed and weighed, thus ranking the animals in
accordance with the number of ticks recovered. On  the day of treat-
ment (day 0), each treated calf was injected subcutaneously with
the test material at dose of 1 mg/kg according to b.w. From day 1 to
day 23 post-treatment (P.T.), engorged female ticks detached from
each animal were collected from the ﬂoor of the stall and counted
daily. Fipronil efﬁcacy in each animal of each day was  calculated
using the formula: Efﬁcacy = 100 − [100 × (A × D)/(B × C)]. Where:
A = mean ticks of untreated group before treatment (days −3, −2(day 0), C = mean ticks of treated group before treatment (days −3,
−2 and −1).
6 Y.P. Cid et al. / Veterinary Parasitology 220 (2016) 4–8
Table  1
Mean ± SE pharmacokinetic parameters of ﬁpronil following subcutaneous
(1 mg/kg) administration to cattle (n = 12).
Parameters Mean ± SE
Cmax (ng/mL) 378.06 ± 137.44
tmax (h) 10.00 ± 0.87
Auc0 t (ng h mL−1) 19388.64 ± 7740.69
Tx. Const. Elim. 0.00277 ± 0.00251
t1/2 (h) 288.17 ± 91.58
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Fig. 2. Mean ± SE number of engorging female Rhipicephalus microplus counted of
each animal daily on untreated and treated cattle with a single subcutaneous injec-
tion of ﬁpronil solution at dose of 1 mg/kg body weight.max: time to reach peak plasma concentration, Cmax: peak plasma concentration,
UC: area under the (zero moment) curve from time 0 to the last detectable con-
entration, t1/2: terminal half-life, Tx. Const. Elim.
In order to obtain oviposition and fertility data, each experimen-
al group provided two samples, containing 10 engorged females
ach, on a daily basis (1–23 days P.T.). Tick samples obtained from
ach animal were weighed collectively, placed in a plastic Petri dish,
nd held in Biochemical oxygen demand (B.O.D) at 27 ± 0.5◦ C and
5 ± 10% relative humidity for 21 days. After that period, from each
ndividual sample, eggs were weighed and placed in plastic syringes
losed with cotton, and returned to the B.O.D. At day 42, the hatch
ate of each sample was visually estimated by comparing the pro-
ortion of unhatched eggs to the proportion of eggshells present in
he vial. Data for tick counts, egg mass weights, and egg hatch for
ver the entire evaluation period were used to calculate the Index
f Fecundity (IF) using the formula reported by Drummond et al.
1973): IF = Weight of eggs (g) × egg hatch (%) × 20000/Weight of
ngorged females.
Calculation of IF provided a method of estimating the reproduc-
ive capacity of the ticks recovered daily from each experimental
roup over the experimental period. The percentage control was
etermined by comparing ticks from treated calves with data
btained from ticks from untreated calves using the follow-
ng formula: % control = (IF of untreated group − IF of treated
roup) × 100/IF of untreated group].
.4. Data analysis
Data on tick number, female weight, egg mass weight, egg hatch
nd IF obtained for untreated and treated females in the therapeutic
ortion of the study (ticks on the host at the time of treatment) were
nalyzed by Mann–Whitney Rank Sum Test to determine differ-
nces for each measured parameter by Bioestat 5.0 program (Ayres
t al., 2007).
. Results
.1. Pharmacokinetics analysis
Clinically no adverse reactions were observed in any of the
attle treated with FIP solution by subcutaneous injection. The ana-
ytical procedures and HPLC analysis of FIP were validated. The
electivity of the method was established by no signiﬁcant inter-
erence or matrix effect observed at the retention times of FIP and
S in spiked plasma samples. The linear regression lines for FIP
n the range between 5 and 500 ng/mL showed correlation coefﬁ-
ients of 0.9993. The inter-day precision of the analytical procedure
btained after HPLC analysis of spiked standards of FIP (5, 100 and
00 ng/mL) showed CV values between 1.6 and 9.9% while the accu-
acy was well within ± 15%. The limit of quantiﬁcation (LOQ) of the
nalytical technique was 5 ng/mL.
Pharmacokinetic parameters of FIP following subcutaneous
1 mg/kg) administration are given in Table 1 with the mean plasma
oncentration vs. time curves shown in Fig. 1. FIP was absorbed into
he blood of treated cattle very quickly after treatment, reaching
6.25–53,75 ng/mL one hour after treatment. Maximum concen-Fig. 3. Mean efﬁcacy of ﬁpronil administrated subcutaneously at a dose of 1 mg/kg
in cattle on evolutives stages: adults, nymphs and larvae.
tration (Cmax) occurred at 10 h (tmax) P.T., at 378.06–137.44 ng/mL.
After tmax, FIP concentration drops dramatically, reaching the range
of 50 ng/mL at 24 h P.T. This level was maintained up to 7 days P.T.
and then dropped to the range of 20 ng/mL at 14–21 days P.T., ﬁnally
reaching levels below the LOQ (5 ng/mL) at 28 days P.T.
3.2. Efﬁcacy studies
The mean of ticks recovered for each valuation day of the study
is shown in Fig. 2. The number of ticks per animal recovered at
pre-treatment period (days −3, −2 and −1) was 9.73 ± 2.70 for the
control group and 12.67 ± 2.47 for the treated group. The mean of
ticks recovered after treatment period ranged from 16.00 ± 15.22 to
70.60 ± 33.76 for the control group and 0.20 ± 0.45 to 46.60 ± 34.41
for the treated group. The statistical analysis (t test for independent
samples) showed no signiﬁcant difference (p > 0.05) of mean of ticks
recovered between control and treated groups at pre-treatment
period and until 3th day P.T. Signiﬁcant differences (p < 0.05) were
noticed from the 4th day to the end of the study.
The minimum efﬁcacy values were observed on the ﬁrst day
after treatment (1.63%), reaching a maximum of 99.39% after nine
days P.T. (Table 2). From the tenth day P.T., efﬁcacy begins to
decrease gradually achieving 73.83% in the last evaluation date (day
+23).
The stratiﬁed efﬁcacy from different forms was  calculated
(Fig. 3). The results showed efﬁcacy values of 74.96% for adults,
92.24% for nymph, and 80.13% for larvae. The mean efﬁcacy was
82.24%.
Y.P. Cid et al. / Veterinary Para
Table  2
Therapeutic efﬁcacy and mean ± SE number of Rhipicephalus microplus female
detached from treated and untreated experimentally infested cattle (stall test).
Post treatment day Untreated Treated
Mean tick number Mean tick number Efﬁcacy (%)
0 9.73 ± 2.70a 12.67 ± 2.47a
1 36.40 ± 35.13 a 46.60 ± 34.41 a 1.63
2  40.60 ± 37.02 a 19.20 ± 19.08 a 63.58
3  31.00 ± 24.85 a 8.00 ± 6.36 a 80.12
4  31.80 ± 22.79 a 2.20 ± 1.79 b 94.67
5  34.60 ± 29.36 a 4.80 ± 5.02 b 89.31
6  31.40 ± 23.80 a 1.40 ± 1.67 b 96.57
7  34.60 ± 25.52 a 0.60 ± 0.89 b 98.66
8  16.00 ± 15.22 a 1.60 ± 2.61 b 92.30
9  24.80 ± 22.77 a 0.20 ± 0.45 b 99.38
10  30.40 ± 23.61 a 3.20 ± 3.83 b 91.89
11  25.20 ± 20.61 a 2.60 ± 4.72 b 92.05
12  37.80 ± 33.98 a 3.60 ± 4.93 b 92.66
13  57.20 ± 38.45 a 7.60 ± 4.83 b 89.77
14  62.80 ± 38.69 a 10.20 ± 12.19 b 87.49
15  65.40 ± 29.75 a 13.20 ± 9.26 b 84.45
16  64.40 ± 35.56 a 13.20 ± 10.47 b 84.21
17  60.80 ± 35.08 a 12.60 ± 10.06 b 84.04
18  51.40 ± 29.98 a 10.80 ± 6.72 b 83.82
19  57.40 ± 32.03 a 12.80 ± 6.38 b 82.82
20  70.60 ± 33.76 a 19.00 ± 15.72 b 79.27
21  58.40 ± 27.79 a 17.20 ± 19.37 b 77.32
22  43.60 ± 23.86 a 16.40 ± 21.05 b 71.03
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89.31–99.38% (4–13 days P.T.) control could be expected only when
T
M
s23  62.40 ± 24.05 a 21.20 ± 23.68 b 73.83
Mean (1–23) 44.74 ± 15,97a 10.79 ± 10.25b 82.24
Table 3 represents the mean number of ticks, weight of the eggs,
gg hatch, index of fertility and percentage of control for untreated
nd treated groups. The number of ticks for the untreated group was
qual to 10 in all evaluated days, whereas in the treated group this
umber varied from 2 to 10. The weight of the eggs ranged from
.100 g to 0.146 g for the untreated group and 0.040 g to 0.145 g
or treated group. The egg hatch ranged from 96.5 to 99.5% for
ntreated group and from 0 to 96.0% for treated group. Percent-
ge control varies from 0 to 100% leading to an average value of
5.69%.
. Discussion
Fipronil pharmacokinetic parameters have already been
ssessed, however at different concentrations, dosages and routes
f administrations. According to Cerkvenik Flajs and Grabnar, 2002,
omparison of results obtained in different experimental condi-
ions such as race, gender, age, route of administration, formulation,
ampling and analytical method becomes inconsistent. Neverthe-
ess, it is possible to determine an average of results, especially in
elation to the average time of drug residence in blood plasma.
Leghait et al. (2009) found concentrations below the LOQ of the
ethod (100 ng/mL) in days assessed after daily administration of
IP by intragastric administration in rats at a dose of 3 mg/kg for
4 days. In another study after oral administration of FIP at a dosage
f 0.5 mg/kg/day in rats for four days, Leghait et al. (2010) found
oncentrations below the LOQ of the assay (50 ng/mL) in all times
valuated for 14 weeks.
Lacroix et al. (2010) found FIP plasma concentration rang-
ng from 10.7 ± 8.6 ng/mL to 231.0 ± 67.3 ng/mL after daily oral
able 3
ean ± SE tick number, weigh of egg, egg hatch, index of fecundity (IF) and percentage of
ingle  subcutaneous injection of ﬁpronil at 1 mg/kg body weigh.
Treatment Number of ticks Weigh of egg (g) Egg ha
Untreated 10.0 ± 0.0a 1.18 ± 0.13a 98.20
Treated  8.9 ± 2.4b 0.75 ± 0.32b 86.98sitology 220 (2016) 4–8 7
administration at a dose of 3 mg/kg in rats for 13 days. Hu et al.
(2006) following a single intravenous administration of FIP at
a dosage of 3 mg/kg in rabbits found Cmax of 3.48 ± 0.52 mg  L−1
in two-compartment model with t1/2 of 1.32 ± 0.11 h and t1/2
3.25 ± 0.59 h. The AUC found was  4.96 ± 1.22 mg  h L−1.
Until now, there have not been reported in the literature studies
involving subcutaneous administration of FIP in any animal species.
The pharmacokinetic parameters in this study establishes that FIP
administered subcutaneously at a dose of 1 mg/kg showed rapid
absorption, reaching peak plasma (Cmax) of 378.06 ± 137.44 ng/mL,
with time corresponding to the peak plasma (tmax) of 10 ± 0.87 h
and high elimination half-life (t1/2 = 12 days). Thus, it is assumed
that FIP subcutaneous administrated in cattle reaches the systemic
circulation with rapidly absorption and slow elimination keeping
quantiﬁable plasma levels (>5 ng/mL) in the blood for up to 21 days
after single treatment at a dose of 1 mg/kg.
Efﬁcacy studies with cattle experimentally infested by R.
microplus, revealed the differentiated action of FIP against the
diverse evolutive stages of this parasite, a fact also reported by other
authors for avermectins (Gonzales et al., 1993; Davey and George,
2002). Reduced action was  observed in the initial P.T. period (1–3),
indicating low efﬁcacy (1.63–80.12%) against the adult forms aged
18–20 days at the time of treatment. Efﬁcacy values improve to
94.67% 4 days P.T., which may  be related to the death of the adult
forms aged approximately 16 days at the time of treatment, adults
which were partially engorged, sucked more blood and conse-
quently had contact with more drug.
Higher efﬁcacy percentages against nymphs were found
(92.24%) stimulating the idea in an effort to this stage takes more
time on the animal (7–14 days), sucking his blood and getting a
greater amount of drug, explaining the good result for nymph.
Following the same reasoning, the expected result did not hap-
pen for the larval stage. Despite being the most sensitive stage
and stay longer on the animal (14–23 days) the efﬁcacy (80.13%)
were lower them nymph stage. It could be explained due to rapid
metabolism of FIP in the blood. Highest values of plasma concentra-
tion occurred on the day of treatment, a period which young larvae
can barely feed on blood.
Due to the lack of sound literature to back up a prior evaluation
about injectable ﬁpronil efﬁcacy in cattle, the percentage efﬁcacy
was calculated based on the number of engorged females detached
between days 1–23 P.T. As a consequence, for a better evaluation of
the potential of ﬁpronil administered subcutaneously, a traditional
approach to the action period seamed to be more appropriate. Our
study indicates that ﬁpronil administered subcutaneously, under
the conditions of the pharmaceutical form, intensiﬁes its acaricidal
action from the fourth day P.T. forward. As recommended by WAAP,
in cases of slow onset of acaricidal action, the approach of percent-
age efﬁcacy should range over any 22 days that it is most effective.
That considered, under a period of action between day 4–26 P.T.
efﬁcacy values raise up to 85.95%, an increased of 5% compared
with the traditional approach.
Comparison of concentration–time proﬁle of FIP in plasma
of treated cattle with efﬁcacy data indicated that a level ofticks were exposed to concentration higher them 40 ng/mL of FIP
during the entire parasitic development period. By contrast, the
resulting level of control decreased to 71.03–87.49% against ticks
 control of Rhipicephalus microplus recovery from untreated and treated cattle after
tch (%) Index of fertility (IF) Percentage control (%)
 ± 0,75a 1039106 ± 205363a –
 ± 19.51b 670457 ± 284073b 35.69
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environmental fate, ecotoxicology, and human health concerns. Rev. Environ.
Contam. Toxicol. 176, 1–66.
VICH, 2000. Topic GL9 (GCP), Guideline for Good Clinical Practices. The European
Agency for the Evaluation of Medicinal Products, Veterinary Medicine and
Information Technology Unit. Y.P. Cid et al. / Veterinar
xposed to concentration below 40 ng/mL (14–23 days P.T.). Indi-
ating that the length of drug exposure at the threshold dose
>40 ng/mL) during the parasitic development of the ticks was  an
mportant factor for raising the expected level of control.
. Conclusion
The present study indicates that the plasma availability of
pronil after subcutaneous injection with a 1 mg/kg dosage in cat-
le provides efﬁcacy against R. microplus above 80%. The potential of
ubcutaneous injection as an alternative treatment route in cattle
ncourage the development of an injectable formulation of ﬁpronil.
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